cipronex 500 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - ciprofloksacīns - apvalkotā tablete - 500 mg
nicorette coolmint 1 mg/devā aerosols izsmidzināšanai mutes dobumā, šķīdums
mcneil ab, sweden - nikotīns - aerosols izsmidzināšanai mutes dobumā, šķīdums - 1 mg/devā
zeldox 80 mg kapsulas
upjohn eesv, netherlands - ziprazidons - kapsula - 80 mg
ciprofloxacin sandoz 500 mg apvalkotās tabletes
sandoz d.d., slovenia - ciprofloksacīns - apvalkotā tablete - 500 mg
nicorette coolberry 1 mg/devā aerosols izsmidzināšanai mutes dobumā, šķīdums
mcneil ab, sweden - nikotīns - aerosols izsmidzināšanai mutes dobumā, šķīdums - 1 mg/devā
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - other nervous system drugs - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastiskie līdzekļi aģentu - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.